[1] |
MAREK J. Multiple nervenentzündung (polyneuritis) bei Hühnern[J]. Dtsch Tierärztl Wochenschr, 1907, 15:417-421.
|
[2] |
BIGGS P M. A discussion on the classification of the avian leucosis complex and fowl paralysis[J]. Br Vet J, 1961, 117(7):326-334. e2.
|
[3] |
CALNEK B W. Pathogenesis of Marek’s disease virus infection[M]//HIRAI K. Marek’s Disease. Berlin:Springer, 2001:25-55.
|
[4] |
BAIGENT S J, DAVISON F. Marek’s disease virus: biology and life cycle[M]//DAVISON F, NAIR V. Marek’s Disease, An Evolving Problem: A Volume in Biology of Animal Infections. Oxford: Elsevier Academic Press, 2004:62-77.
|
[5] |
GATHERER D, DEPLEDGE D P, HARTLEY C A, et al. ICTV virus taxonomy profile:herpesviridae 2021[J]. J Gen Virol, 2021, 102(10):001673.
|
[6] |
WITTER R L. Increased virulence of Marek’s disease virus field isolates[J]. Avian Dis, 1997, 41(1):149-163.
|
[7] |
WITTER R L, CALNEK B W, BUSCAGLIA C, et al. Classification of Marek’s disease viruses according to pathotype:philosophy and methodology[J]. Avian Pathol, 2005, 34(2):75-90.
|
[8] |
RISPENS B H, VAN VLOTEN H, MASTENBROEK N, et al. Control of Marek’s disease in the Netherlands. I. Isolation of an avirulent Marek’s disease virus (strain CVI 988) and its use in laboratory vaccination trials[J]. Avian Dis, 1972, 16(1):108-125.
|
[9] |
SMITH M W, CALNEK B W. Effect of virus pathogenicity on antibody production in Marek’s disease[J]. Avian Dis, 1973, 17(4):727-736.
|
[10] |
SEVOIAN M, CHAMBERLAIN D M, COUNTER F T. Avian lymphomatosis. I. Experimental reproduction of the neural and visceral forms[J]. Vet Med, 1962, 57:500-501.
|
[11] |
EIDSON C S, SCHMITTLE S C. Studies on acute Marek’s disease I. Characteristics of isolate GA in chickens[J]. Avian Dis, 1968, 12(3):467-476.
|
[12] |
PURCHASE H G, BIGGS P M. Characterization of five isolates of Marek’s disease[J]. Res Vet Sci, 1967, 8(4):440-453.
|
[13] |
WITTER R L, SHARMA J M, FADLY A M. Pathogenicity of variant Marek’s disease virus isolants in vaccinated and unvaccinated chickens[J]. Avian Dis, 1980, 24(1):210-232.
|
[14] |
SCHAT K A, CALNEK B W, FABRICANT J. Characterisation of two highly oncogenic strains of Marek’s disease virus[J]. Avian Pathol, 1982, 11(4):593-605.
|
[15] |
许晓云, 孙爱军, 崔言顺, 等. 带有REV-LTR片段的马立克氏病病毒重组野毒株与超强毒株致病性和横向传播性比较[J]. 微生物学报, 2009, 49(4):540-543.XU X Y, SUN A J, CUI Y S, et al. Comparision of pathogenicity and horizontal transmission ability between recombinant Marek’s disease virus field strain with REV-LTR and a very virulent reference strain[J]. Acta Microbiologica Sinica, 2009, 49(4):540-543. (in Chinese)
|
[16] |
TENG M, ZHENG L P, LI H Z, et al. Pathogenicity and pathotype analysis of Henan isolates of Marek’s disease virus reveal long-term circulation of highly virulent MDV variant in China[J]. Viruses, 2022, 14(8):1651.
|
[17] |
ZHENG L P, TENG M, LI G X, et al. Current epidemiology and co-infections of avian immunosuppressive and neoplastic diseases in chicken flocks in central China[J]. Viruses, 2022, 14(12):2599.
|
[18] |
DENG Q M, SHI M Y, LI Q H, et al. Analysis of the evolution and transmission dynamics of the field MDV in China during the years 1995-2020, indicating the emergence of a unique cluster with the molecular characteristics of vv+ MDV that has become endemic in southern China[J]. Transbound Emerg Dis, 2021, 68(6):3574-3587.
|
[19] |
SONG B L, ZEB J, HUSSAIN S, et al. A review on the Marek’s disease outbreak and its virulence-related meq genovariation in Asia between 2011 and 2021[J]. Animals, 2022, 12(5):540.
|
[20] |
张文凯, 董松岭, 滕 蔓, 等. 马立克病病毒分子生物学检测技术研究进展[J]. 畜牧与兽医, 2022, 54(8):132-138.ZHANG W K, DONG S L, TENG M, et al. Latest progress on molecular biological techniques for detection of Marek’s disease virus[J]. Animal Husbandry & Veterinary Medicine, 2022, 54(8):132-138. (in Chinese)
|
[21] |
IKUTA K, HONMA H, MAOTANI K, et al. Monoclonal antibodies specific to and cross-reactive with Marek’s disease virus and herpesvirus of turkeys[J]. Biken J, 1982, 25(4):171-175.
|
[22] |
LEE L F, LIU X, WITTER R L. Monoclonal antibodies with specificity for three different serotypes of Marek’s disease viruses in chickens[J]. J Immunol, 1983, 130(2):1003-1006.
|
[23] |
韦 毅, 赵晓岩, 徐宜为. 鸡马立克氏病病毒(MDV)单克隆抗体(McAb)的研究I. 抗血清Ⅰ型MDV-McAb的制备及其主要特性的研究[J]. 中国畜禽传染病, 1989, 4(3):114-118, 85.WEI Y, ZHAO X Y, XU Y W. Study on the Monoclonal Antibody (McAb) of Chicken Marek’s Disease Virus (MDV) preparation of antiserum Type 1 MDV-McAb and its main characteristics[J]. Chinese Infectious Diseases of Livestock and Poultry, 1989, 4(3):114-118, 85. (in Chinese)
|
[24] |
钱建飞, 陈溥言, 蔡宝祥. 马立克氏病病毒单克隆抗体研究Ⅰ. 马立克氏病病毒和火鸡疱疹病毒单克隆抗体杂交瘤细胞株的建立和鉴定[J]. 中国畜禽传染病, 1992, 65(4):39-42.QIAN J F, CHEN P Y, CAI B X. Study on Monoclonal antibody to Marek’s disease virus. I. Establishment and identification of hybridoma cell lines with monoclonal antibodies to Marek’s disease virus and Turkey Herpesvirus[J]. Chinese Infectious Diseases of Livestock and Poultry, 1992, 65(4):39-42. (in Chinese)
|
[25] |
韩凌霞. 马立克氏病病毒gB、gI、pp38基因的原核系统表达及其特异性单抗的研制和初步应用[D]. 扬州:扬州大学, 2001.HAN L X. Prokaryotic expression of the genes gB, gI and pp38 of Marek’s disease virus and preparation and application of their specific monoclonal antibodies[D]. Yangzhou:Yangzhou University, 2001. (in Chinese)
|
[26] |
高俊娜, 张幸星, 连 雪, 等. 马立克病病毒Meq单克隆抗体的制备[J]. 中国兽医科学, 2016, 46(9):1073-1078.GAO J N, ZHANG X X, LIAN X, et al. Generation of monoclonal antibodies against Marek’s disease virus oncoprotein Meq[J]. Chinese Veterinary Science, 2016, 46(9):1073-1078. (in Chinese)
|
[27] |
韦 平, 崔治中, 龙进学, 等. 马立克氏病病毒MEQ蛋白单克隆抗体的制备及应用研究[J]. 广西大学学报:自然科学版, 2002, 27(1):5-9.WEI P, CUI Z Z, LONG J X, et al. The development of monoclonal antibody (McAb) against MEQ protein of Marek’s disease virus(MDV)and its applications[J]. Journal of Guangxi University:Natural Science Edition, 2002, 27(1):5-9. (in Chinese)
|
[28] |
李巧玲, 崔红玉, 牛军伟, 等. 马立克氏病病毒gE蛋白单克隆抗体的制备及鉴定[J]. 中国兽医科学, 2013, 43(5):510-514.LI Q L, CUI H Y, NIU J W, et al. Preparation and identification of monoclonal antibody against glycoprotein E protein of Marek’s disease virus[J]. Chinese Veterinary Sciences, 2013, 43(5):510-514. (in Chinese)
|
[29] |
BIGGS P M, NAIR V. The long view:40 years of Marek’s disease research and Avian Pathology[J]. Avian Pathol, 2012, 41(1):3-9.
|
[30] |
TENG M, ZHU Z J, YAO Y X, et al. Critical roles of non-coding RNAs in lifecycle and biology of Marek’s disease herpesvirus[J]. Sci China Life Sci, 2023, 66(2):251-268.
|
[31] |
OSTERRIEDER N, KAMIL J P, SCHUMACHER D, et al. Marek’s disease virus:from miasma to model[J]. Nat Rev Microbiol, 2006, 4(4):283-294.
|
[32] |
CHI X J, LU Y X, ZHAO P, et al. Interaction domain of glycoproteins gB and gH of Marek’s disease virus and identification of an antiviral peptide with dual functions[J]. PLoS One, 2013, 8(2): e54761.
|
[33] |
DAVIDSON I. Out of sight, but not out of mind:aspects of the avian oncogenic Herpesvirus, Marek’s disease virus[J]. Animals, 2020, 10(8):1319.
|
[34] |
YANAGIDA N, OGAWA R, LI Y, et al. Recombinant fowlpox viruses expressing the glycoprotein B homolog and the pp38 gene of Marek’s disease virus[J]. J Virol, 1992, 66(3):1402-1408.
|
[35] |
宋利娜, 滕 蔓, 郑鹿平, 等. 马立克病病毒单克隆抗体的制备[J]. 中国兽医科学, 2018, 48(9):1102-1108.SONG L N, TENG M, ZHENG L P, et al. Development of monoclonal antibodies against Marek’s disease virus[J]. Chinese Veterinary Sciences, 2018, 48(9):1102-1108. (in Chinese)
|
[36] |
TENG M, ZHOU Z Y, YAO Y X, et al. A new strategy for efficient screening and identification of monoclonal antibodies against oncogenic avian herpesvirus utilizing CRISPR/Cas9-based gene-editing technology[J]. Viruses, 2022, 14(9):2045.
|
[37] |
TENG M, LIU J L, LUO Q, et al. Efficient cross-screening and characterization of monoclonal antibodies against Marek’s disease specific Meq oncoprotein using CRISPR/Cas9-gene-edited viruses[J]. Viruses, 2023, 15(4):817.
|